NORDIC BIOTECH K/S: Financial statements 2024
CVR: 26290724
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000. The solvency ratio was 99.9%.
- Gross Profit
- DKK -157,000
- Profit/Loss
- DKK 101,458,000
- Equity
- DKK 127,032,000
- Total Assets
- DKK 127,129,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -157K | 101.5M | 127M | - |
| 2023 | - | -133K | 1.3M | 32.2M | - |
| 2022 | - | - | -44.6M | 34.2M | 0 |
| 2021 | - | - | -6.4M | 78.7M | 0 |
| 2020 | - | - | -1.4M | 85.1M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
NORDIC BIOTECH K/S has published its annual report for 2023. Gross profit came to DKK -133,000, and the net result was DKK 1,254,000.
About NORDIC BIOTECH K/S
NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.
